Halozyme Therapeutics | HALO - 税前利润

股票价格
67.82
每天变化
0.74 1.10%
每月一次
2.02%
每年
12.62%
Q2 预测
65.97


金融业
股票价格
USD
资产
USD 2.53B
现金及等价物
USD 133.82M
销售成本
USD 102.15M
流动资产
USD 825.21M
流动负债
USD 177.09M
债务
USD 1.51B
EBIT
USD -88.41M
EBITDA
USD 21.9M
员工
350
EPS每股收益
USD -0.24
股本和储备
USD 48.81M
销售毛利
USD 281.77M
债务利息支出
USD 4.91M
贷款资金
USD 2.14B
市值
USD 8.57B
净收入
USD -141.59M
营业费用
USD 211.07M
营业利润
USD -88.41M
普通股股本
USD 117.78M
PE价格收益
23.16
税前利润
USD 218.96M
销售收入
USD 451.76M
销售和管理费用
USD 64.64M
股票
USD 176.48M
贸易债权人
USD 20.9M
应收帐款人
USD 441.27M


税前利润 更改 日
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amarin USD -852K 7.26M 2025-12
Amgen USD 3.92B 2.35B 2025-09
Baxter International USD 121M 12M 2025-09
Cara Therapeutics USD -4.91M 3.17M 2025-03
Cytokinetics USD -183.03M 123.15M 2025-12
DBV Technologies USD -33.16M 8.6M 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 63.67M 95M 2025-12
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Intrexon USD -60.48M 27.09M 2024-06
Ionis Pharmaceuticals USD -228M 99M 2025-12
MannKind USD -20.93M 28.71M 2025-12
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Pfizer USD 3.33B 290M 2025-09
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
United Therapeutics USD 444M 6M 2025-12
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12